Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8235-8247
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8235
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8235
Table 3 Noninvasive parameters according to endoscopic activity grade in colonic or ileo-colonic Crohn’s disease patients
| Inactive, n1 = 21 | Mild activity, n2 = 8 | Moderate activity, n3 = 9 | Severe activity, n4 = 18 | |||||
| FC, median (range) | 125.7(0-658.7) | 717.8 (137.7-1805.0) | 1211.8 (660.8-1805.0) | 1805.0 (264.6-2266.1) | ||||
| P value | < 0.05 | NS | < 0.05 | |||||
| CDAI, median (range) | 63.1 (32.2-155.0) | 125.4 (46.8-157.8) | 145.1 (75.0-234.9) | 201.4 (64.7-364.0) | ||||
| P value | < 0.05 | NS | < 0.05 | |||||
| CRP, median (range) | 0.48(0.1-12.9) | 5.1 (0.20-48.1) | 15.0 (0.6-70.8) | 30.6 (1.1-79.8) | ||||
| P value | NS | NS | < 0.05 | |||||
| ESR, median (range) | 8.0(1.0-57.0) | 22.0 (5.0-68.0) | 28.0 (8.9-95.0) | 37.0 (5.5-123.0) | ||||
| P value | NS | NS | < 0.05 | |||||
| PCT, median (range) | 0.037 (0-4.39) | 0.038 (0.021-0.064) | 0.038 (0-0.137) | 0.049 (0.02-5.02) | ||||
| P value | NS | NS | NS | |||||
- Citation: Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World J Gastroenterol 2017; 23(46): 8235-8247
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8235.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8235